Drug Comparisons & Clinical Research
Weight Outcomes With Sitagliptin vs. GLP-1 Receptor Agonists: What the Clinical Evidence Actually Tells Us
As newer injectable medications like semaglutide and tirzepatide dominate headlines for their dramatic weight loss effects, many patients wonder where Sitagliptin fits into the picture. This article examines the clinical research comparing DPP-4 inhibitors and GLP-1 receptor agonists on body weight, helping patients make informed conversations with their healthcare providers about what to realistically expect from each drug class.